Germany – Pharmaceutical products – Open house drug discount contracts for the active ingredient iron(III) derisomaltose, ATC B03AC08

Original title (German): Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Eisen(III)-Derisomaltose, ATC B03AC08

Health · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

May 31, 2027

Response Due

Active

Status

Opportunity Overview

Germany – Pharmaceutical products – Open house drug discount contracts for the active ingredient iron(III) derisomaltose, ATC B03AC08

This Germany Pharmaceuticals opportunity is one most of your competitors will never see.

How to bid: GlobalGov tracks this tender; it does not accept bids. Submit your response through the issuing agency’s official notice.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start a free GlobalGov account

Solicitation Details

Issuing agency	Health
Country	Germany
Category	Pharmaceuticals
Published	June 18, 2025
Procurement stage	Active solicitation
Response due	May 31, 2027
Status	Open — accepting responses
Original language	German — members read it in their own language
Official source	View original notice
Last verified	October 11, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Germany market overview →Pharmaceuticals tenders in Germany →Browse all categories →

Related Opportunities in Germany

Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.06.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu Wirkstoffen (Arzneimitteln) - VV 85

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Teriparatid

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Icatibant, ATC B06AC02

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Aflibercept, ausgenommen 114,3 mg/ml, ATC S01LA05

Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-04

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Propranolol, als Lösung zum Einnehmen, ATC C07AA05

Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte according to § 130a Abs.8 SGB V mit jederzetiger Beitrittsmöglichkeit, sog. Approval model 2025-01

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.